Center for Pharmaceutical Policy and Prescribing Publications

Selected Publications

Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply
Inmaculada Hernandez, PharmD, PhD; Vinay Prasad, MD, MPH; Walid F. Gellad, MD, MPH
JAMA Oncology, October 11, 2018

Changes in Drug Pricing After Drug Shortages in the United States
Inmaculada Hernandez, PharmD, PhD; Shivani Sampathkumar, BS; Chester B. Good, MD, MPH; Aaron S. Kesselheim, MD, JD, MPH; William H. Shrank, MD, MSHS
Annals of Internal Medicine, September 18, 2018.

Doughnuts and Discounts – Changes to Medicare Part D under the Bipartisan Budget Act of 2018
Julie M. Donohue, PhD, and Haiden A. Huskamp, PhD
New England Journal of Medicine, May 24, 2018

Discounted Drugs for Needy Patients and Hospitals — Understanding the 340B Debate
Walid F. Gellad, MD, MPH, and A. Everette James, JD, MBA
New England Journal of Medicine, February 8, 2018


2019 Publications

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
Inmaculada Hernandez, Meiqi He, Nemin Chen, Maria M. Brooks, Samir Saba, and Walid F. Gellad
Journal of the American Heart Association, June 18, 2019

Comparison of Opioid Prescribing by Dentists in the United States and England
Katie J. Suda; Michael J. Durkin; Gregory S. Calip; Walid F. Gellad; Hajwa Kim; Peter B. Lockhart; Susan A. Rowan; Martin H. Thornhill
JAMA Network Open, May 24, 2019

The Limitations of Poor Broadband Internet Access for Telemedicine Use in Rural America: An Observational Study
Coleman Drake, PhD; Yuehan Zhang, ScM; Krisda H. Chaiyachati, MD, MPH, MSHP; Daniel Polsky, PhD
Annals of Internal Medicine, May 21. 2019

Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare
Thomas R. Radomski, Xinhua Zhao, Joseph T. Hanlon, Joshua M. Thorpe, Carolyn T. Thorpe, Jennifer G. Naples, Florentina E. Sileanu, John P. Cashy, Jennifer A. Hale, Maria K. Mor, Leslie R.M. Hausmann, Julie M. Donohue, Katie J. Suda, Kevin T. Stroup, Chester B. Good, Michael J. Fine, Walid F. Gellad
Healthcare, April 26, 2019

Cardiac Resynchronization Therapy Using Pacemakers versus Defibrillators in Patients with Non-Ischemic Cardiomyopathy: The United States Experience from 2007 to 2014
Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I
Heart Rhythm, April 17, 2019

Disparities in Quality of Primary Care by Resident and Staff Physicians: Is There a Conflict Between Training and Equity?
Utibe R. Essien, Wei He, Alaka Ray, Yuchiao Chang, Jonathan R. Abraham, Daniel E. Singer, Steven J. Atlas
Journal of General Internal Medicine, April 8, 2019

Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data
Inmaculada Hernandez, William H. Shrank, Chester B. Good, Walid F. Gellad
Journal of General Internal Medicine, April 3, 2019

A New Safe Harbor — Turning Drug Rebates into Discounts in Medicare Part D
Walid F. Gellad, M.D., M.P.H., Molly Ennis, M.P.H., and Courtney C. Kuza, Ph.D., M.P.H.
The New England Journal of Medicine, April 3, 2019

Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018
Inmaculada Hernandez, PharmD, PhD; Chester B. Good, MD, MPH; William H. Shrank, MD, MSHS; Walid F. Gellad, MD, MPH
JAMA, March 25, 2019

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions
Wei-Hsuan Lo-Ciganic, PhD; James L. Huang, PhD; Hao H. Zhang, PhD; Jeremy C. Weiss, MD, PhD; Yonghui Wu, PhD; C. Kent Kwoh, MD; Julie M. Donohue, PhD; Gerald Cochran, PhD; Adam J. Gordon, MD, MPH; Daniel C. Malone, PhD; Courtney C. Kuza, PhD; Walid F. Gellad, MD, MPH
JAMA Network Open, March 22, 2019

The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder
Evan S. Cole, Ellen DiDomenico, Gerald Cochran, Adam J. Gordon, Walid F. Gellad, Janice Pringle, Jack Warwick, Chung-Chou H. Chang, Joo Yeon Kim, Julie Kmiec, David Kelley, Julie M. Donohue
Journal of General Internal Medicine, March 18, 2019

Is There an Opioid Crisis in Nursing Homes?
Jennifer Pruskowski, PharmD, BCPS, BCGP, CPE, Joseph T. Hanlon, PharmD, MS
The Journal of Post-Acute and Long-Term Care Medicine, March 2019

On The Use Of List Prices In Drug Pricing Research
Inmaculada Hernandez, Walid Gellad
Health Affairs Blog, March 14, 2019

Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case–Control Study
Patience Moyo, PhD; Xinhua Zhao, PhD; Carolyn T. Thorpe, PhD, MPH; Joshua M. Thorpe, PhD, MPH; Florentina E. Sileanu, MS; John P. Cashy, PhD; Jennifer A. Hale, BA; Maria K. Mor, PhD; Thomas R. Radomski, MD, MS; Julie M. Donohue, PhD; Leslie R.M. Hausmann, PhD; Joseph T. Hanlon, PharmD, MS; Chester B. Good, MD, MPH; Michael J. Fine, MD, MSc; Walid F. Gellad, MD, MPH
Annals of Internal Medicine, March 12, 2019

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors
Alvaro San-Juan-Rodriguez, PharmD; Max V. Prokopovich, BS; William H. Shrank, MD, MSHS; Chester B. Good, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA Internal Medicine, February 18, 2019

Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness
Yael Schenker, Seo Young Park, Kwonho Jeong, Jennifer Pruskowski, Dio Kavalieratos, Judith Resick, Amy Abernethy, Jean S. Kutner
Journal of General Internal Medicine, February 4, 2019

Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals
Natasha Parekh, Yael Schenker, Chester B. Good, Lynn Neilson, William H. Shrank
Journal of General Internal Medicine, February 4, 2019

Development of a required longitudinal residency experience focused on deprescribing
Jennifer Pruskowski, Pharm.D., BCPS, BCGP, CPE, Heather Sakely, Pharm.D., BCPS, BCGP, Steven Handler, M.D., Ph.D., CMD
American Journal of Health-System Pharmacy, January 21, 2019

Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM)
Matthew Chinman, Walid F. Gellad, Sharon McCarthy, Adam J. Gordon, Shari Rogal, Maria K. Mor, and Leslie R. M. Hausmann
Implementation Science, January 18, 2019

Assessment of Spending in Medicare Part D If Medication Prices From the Department of Veterans Affairs Were Used
Brett Venker, PharmD; Kevin B. Stephenson, MD; Walid F. Gellad, MD, MPH
JAMA Internal Medicine, January 14, 2019

Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness
Taeko Minegishi, MS, Austin B. Frakt, PhD, Melissa M. Garrido, PhD, Walid F. Gellad, MD,MPH, Leslie R. M. Hausmann, PhD, Eleanor T. Lewis, PhD, Steven D. Pizer, PhD, Jodie A. Trafton, PhD & Elizabeth M. Oliva, PhD
Substance Abuse, January 8, 2019

Treating Pain—The Cannabis Conundrum
Chester B. Good, MD, MPH; Natasha Parekh, MD, MS; Kavita Fischer, MD; James Schuster, MD; Chronis Manolis, RPh; William Shrank, MD, MSHS
Annals of Internal Medicine, January 8, 2019

The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs
Inmaculada Hernandez, Chester B. Good, David M. Cutler, Walid F. Gellad, Natasha Parekh, and William H. Shrank
Health Affairs, January 7, 2019


Publications 2012-2018